Skip to content

The effect of melatonin on the eradication of Helicobacter pylori

Effect of melatonin addition to quadruple therapy (Bismuth, Amoxicillin, Metronidazole, Proton pump inhibitors) for the eradication of Helicobacter pylori (H.pylori) in people who have proven H.pylori infection

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016082111192N5
Enrollment
80
Registered
2017-04-08
Start date
2016-01-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori. Disease of stomach and duodenum, unspecified

Interventions

Intervention 1: Intervention 1: Addition of melatonin tablet orally 3 mg/d to eradication regimen of Helicobacter pylori for 2 weeks. Intervention 2: Intervention 2:Addition of melatonin placebo 1 tab
Treatment - Drugs
Intervention 1: Addition of melatonin tablet orally 3 mg/d to eradication regimen of Helicobacter pylori for 2 weeks
Intervention 2:Addition of melatonin placebo 1 tablet per day orally to eradication regimen of Helicobacter pylori for 2 weeks

Sponsors

Vice chancellor for research, Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients in need of eradication of Helicobacter pylori ( H.pylori) in Taleghani Hospital by obtaining personal wright Exclusion criteria: People who have proven that H. pylori infection but not require treatment

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Eradication of Helicobacter pylori. Timepoint: 1month after finishing drugs. Method of measurement: Assessing the stool antigen test.

Secondary

MeasureTime frame
Side effects of the treatment regimen. Timepoint: 1 month after finishing drugs. Method of measurement: asking patients.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNima Naderi

Deputy of research, School of Pharmacy, Shahid Beheshty Universiti of Medical Sciences

naderi@sbmu.ac.ir00

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026